These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 9886755

  • 1. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D, Idänpään-Heikkilä JJ, Guilbaud G, Kayser V.
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [Abstract] [Full Text] [Related]

  • 2. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
    Christensen D, Guilbaud G, Kayser V.
    Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
    [Abstract] [Full Text] [Related]

  • 3. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
    Martinez V, Christensen D, Kayser V.
    Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
    [Abstract] [Full Text] [Related]

  • 4. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Christensen D, Gautron M, Guilbaud G, Kayser V.
    Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
    [Abstract] [Full Text] [Related]

  • 5. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
    Buritova J, Le Guen S, Fournié-Zaluski MC, Roques BP, Besson JM.
    Eur J Pain; 2003 Dec; 7(3):241-9. PubMed ID: 12725847
    [Abstract] [Full Text] [Related]

  • 6. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD, Carrigan KA, Dykstra LA.
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [Abstract] [Full Text] [Related]

  • 7. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
    Christensen D, Guilbaud G, Kayser V.
    Neuropharmacology; 2000 Jul 10; 39(9):1589-95. PubMed ID: 10854903
    [Abstract] [Full Text] [Related]

  • 8. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
    Idänpään-Heikkilä JJ, Perrot S, Guilbaud G, Kayser V.
    Eur J Pharmacol; 1997 May 01; 325(2-3):155-64. PubMed ID: 9163562
    [Abstract] [Full Text] [Related]

  • 9. Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist.
    Adam F, Bonnet F, Le Bars D.
    Neuropharmacology; 2006 Aug 01; 51(2):191-202. PubMed ID: 16713606
    [Abstract] [Full Text] [Related]

  • 10. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
    Wegert S, Ossipov MH, Nichols ML, Bian D, Vanderah TW, Malan TP, Porreca F.
    Pain; 1997 May 01; 71(1):57-64. PubMed ID: 9200174
    [Abstract] [Full Text] [Related]

  • 11. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus.
    Bordi F, Quartaroli M.
    Pain; 2000 Feb 01; 84(2-3):213-24. PubMed ID: 10666526
    [Abstract] [Full Text] [Related]

  • 12. N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
    Kayser V, Latrémolière A, Hamon M, Bourgoin S.
    Eur J Pain; 2011 May 01; 15(5):451-8. PubMed ID: 20965753
    [Abstract] [Full Text] [Related]

  • 13. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
    Blackburn-Munro G, Bomholt SF, Erichsen HK.
    Neuropharmacology; 2004 Sep 01; 47(3):351-62. PubMed ID: 15275824
    [Abstract] [Full Text] [Related]

  • 14. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
    Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, Pietra C, Rondelli I, Chamiot-Clerc P, Simonato M, Barbieri M.
    J Pharmacol Exp Ther; 2003 Aug 01; 306(2):804-14. PubMed ID: 12750440
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy.
    Nichols ML, Lopez Y, Ossipov MH, Bian D, Porreca F.
    Pain; 1997 Feb 01; 69(3):317-322. PubMed ID: 9085307
    [Abstract] [Full Text] [Related]

  • 16. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
    Idänpään-Heikkilä JJ, Guilbaud G, Kayser V.
    J Pharmacol Exp Ther; 1997 Sep 01; 282(3):1366-72. PubMed ID: 9316848
    [Abstract] [Full Text] [Related]

  • 17. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.
    Quartaroli M, Fasdelli N, Bettelini L, Maraia G, Corsi M.
    Eur J Pharmacol; 2001 Nov 02; 430(2-3):219-27. PubMed ID: 11711034
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors.
    Mehta AK, Halder S, Khanna N, Tandon OP, Sharma KK.
    Hum Exp Toxicol; 2012 Jan 02; 31(1):51-6. PubMed ID: 21803783
    [Abstract] [Full Text] [Related]

  • 19. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
    Holtman JR, Crooks PA, Johnson-Hardy J, Wala EP.
    Pharmacol Biochem Behav; 2008 Oct 02; 90(4):769-77. PubMed ID: 18582492
    [Abstract] [Full Text] [Related]

  • 20. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W, Kozela E, Parsons CG, Sladek M, Bauer T, Popik P.
    Neuropharmacology; 2005 Mar 02; 48(3):360-71. PubMed ID: 15721168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.